| Financial Year |
March 31 2023 |
| Monetary Funds |
1,746,684,900.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
5,320,961,128.00 |
| Advances to Suppliers |
13,005,201.00 |
| Other Receivables |
339,946,475.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
228,687,817.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,294,075.00 |
| Total Current Assets |
7,719,579,596.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,226,479.00 |
| Long-term Equity Investment |
280,850,648.00 |
| Investment Properties |
-- |
| Fixed Assetes |
23,033,523,387.00 |
| Under-construction Projects |
1,111,749,563.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,713,990,920.00 |
| R&D expenses |
-- |
| Goodwill |
281,254,606.00 |
| Long-Term Deferred and Prepaid Expenses |
36,750,938.00 |
| Deferred Income Tax Assets |
1,124,255,732.00 |
| Other Non-Current Assets |
64,055,463.00 |
| Sub-Total of Non-Current Assets |
29,495,285,814.00 |
| Total Assets |
37,214,865,410.00 |
| Short-Term Loans |
700,530,444.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
400,000,000.00 |
| Accounts Payable |
4,556,545,192.00 |
| Accounts Received In Advance |
107,081,876.00 |
| Employee Compensation Payable |
604,289,717.00 |
| Taxes Payable |
71,992,530.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,464,903,372.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
85,866,093.00 |
| Other Current Liabilities |
1,157,877.00 |
| Sub-Total of Current Liabilities |
8,132,984,882.00 |
| Long-term Loans |
1,275,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,303,929.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,393,336,736.00 |
| Total Liabilities |
11,526,321,618.00 |
| Paid-In Capital(Or Share Stock) |
7,083,537,000.00 |
| Capital Surplus |
11,573,824,915.00 |
| Surplus Reserve |
3,084,484,726.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,717,593,985.00 |
| Minority Stockholder's Interest |
-36,170,906.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,724,714,698.00 |
| Owner's Equity（Stockholder's Equity） |
25,688,543,792.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,214,865,410.00 |
